rs7199221

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_022468.5(MMP25):​c.661+1092G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.329 in 151,904 control chromosomes in the GnomAD database, including 8,709 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.33 ( 8707 hom., cov: 31)
Exomes 𝑓: 0.23 ( 2 hom. )

Consequence

MMP25
NM_022468.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.424

Publications

10 publications found
Variant links:
Genes affected
MMP25 (HGNC:14246): (matrix metallopeptidase 25) Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMPs are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. However, the protein encoded by this gene is a member of the membrane-type MMP (MT-MMP) subfamily, attached to the plasma membrane via a glycosylphosphatidyl inositol anchor. In response to bacterial infection or inflammation, the encoded protein is thought to inactivate alpha-1 proteinase inhibitor, a major tissue protectant against proteolytic enzymes released by activated neutrophils, facilitating the transendothelial migration of neutrophils to inflammatory sites. The encoded protein may also play a role in tumor invasion and metastasis through activation of MMP2. The gene has previously been referred to as MMP20 but has been renamed MMP25. [provided by RefSeq, Jul 2008]
MMP25-AS1 (HGNC:51372): (MMP25 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.44 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MMP25NM_022468.5 linkc.661+1092G>A intron_variant Intron 4 of 9 ENST00000336577.9 NP_071913.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MMP25ENST00000336577.9 linkc.661+1092G>A intron_variant Intron 4 of 9 1 NM_022468.5 ENSP00000337816.4

Frequencies

GnomAD3 genomes
AF:
0.328
AC:
49845
AN:
151756
Hom.:
8679
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.444
Gnomad AMI
AF:
0.316
Gnomad AMR
AF:
0.266
Gnomad ASJ
AF:
0.257
Gnomad EAS
AF:
0.161
Gnomad SAS
AF:
0.271
Gnomad FIN
AF:
0.390
Gnomad MID
AF:
0.315
Gnomad NFE
AF:
0.284
Gnomad OTH
AF:
0.313
GnomAD4 exome
AF:
0.233
AC:
7
AN:
30
Hom.:
2
Cov.:
0
AF XY:
0.250
AC XY:
6
AN XY:
24
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.182
AC:
4
AN:
22
Other (OTH)
AF:
0.750
AC:
3
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.329
AC:
49928
AN:
151874
Hom.:
8707
Cov.:
31
AF XY:
0.331
AC XY:
24557
AN XY:
74190
show subpopulations
African (AFR)
AF:
0.445
AC:
18419
AN:
41382
American (AMR)
AF:
0.266
AC:
4064
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.257
AC:
893
AN:
3470
East Asian (EAS)
AF:
0.161
AC:
832
AN:
5180
South Asian (SAS)
AF:
0.271
AC:
1304
AN:
4806
European-Finnish (FIN)
AF:
0.390
AC:
4102
AN:
10520
Middle Eastern (MID)
AF:
0.315
AC:
92
AN:
292
European-Non Finnish (NFE)
AF:
0.284
AC:
19272
AN:
67954
Other (OTH)
AF:
0.315
AC:
664
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1676
3352
5029
6705
8381
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
488
976
1464
1952
2440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.285
Hom.:
11637
Bravo
AF:
0.322
Asia WGS
AF:
0.235
AC:
819
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
6.0
DANN
Benign
0.41
PhyloP100
0.42
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7199221; hg19: chr16-3101639; API